![](/img/cover-not-exists.png)
Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer
Tzeng, Ching-Wei D., Balachandran, Aparna, Ahmad, Mediha, Lee, Jeffrey E., Krishnan, Sunil, Wang, Huamin, Crane, Christopher H., Wolff, Robert A., Varadhachary, Gauri R., Pisters, Peter W. T., Aloia,Volume:
16
Language:
english
Journal:
HPB
DOI:
10.1111/hpb.12154
Date:
May, 2014
File:
PDF, 264 KB
english, 2014